圖示 系所成員
李名鏞
職稱: 副教授
公告者:ywtseng | 公告時間:2018/2/11
李名鏞
姓名: 李名鏞
職稱: 副教授
研究室: 靜宜321
E-Mail: mylee@pu.edu.tw
分機: 15129
專長: 臨床試驗、可靠度工程 、研究設計與資料分析、實驗設計

李名鏞 Ming-Yung Lee

最高學歷:

國立清華大學統計學博士

職  稱:

副教授

專長學科:

[1]臨床試驗

[2]機器學習與資料採礦

[3]實驗設計

[4]可靠度分析

[5]生物統計

 

學位論文:

  1. Ming-Yung Lee (2006/8). Estimations of Lifetime Distribution and Optimal Design of Degradation EXperiments for Wiener Degradation Process. Ph.D. dissertation, 清華大學統計學研究所, 新竹.

著作目錄

A.期刊論文:

  1. Mai-Yi Fan, Sabrina; Cheng, Yu-Pin; Lee, Ming-Yung; Lin, Sung-Jan; Chiu, Hsien-Yi (2018/6/27). Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-comparison, Sham– device Controlled Trial. Dermatologic Surgery.[SCI]
  2. Cheng-Hung Hu, Ming-Yung Lee (2018/4/1). COMPARISON AMONG SEVERAL COMMONLY USED SAMPLING METHODS FOR A DEGRADATION TEST. Quality and Reliability Engineering International, Vol. 34 , No. 3 , p.p.436 -458 .[SCI]
  3. Ming-Yung Lee, Cheng-Hung Hu, and Jen Tang (2017/8/21). A Two-Stage Latent Variable Estimation Procedure for Time-Censored Accelerated Degradation Tests. IEEE Transactions on Reliability, Vol. 66 , No. 4 , p.p.1266 -1279 .[SCI]
  4. Kuang-Lee Chang, Ming-Yung Lee, Wan-Ru Chao and Chih-Ping Han* (2016/12). The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma. Human Genomics, Vol. 10 , No. 1 .[SCI]
  5. Yi-Ju Lee; Ming-Yung Lee; Alexandra Ruan; Chi-Kuan Chen; Hao-Ping Liu; Chau-Jong Wang; Wan-Ru Chao; and Chih-Ping Han (2016/11/18). Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms. Oncotarget, Vol. 7 , No. 50 , p.p.097 -82103 .[SCI]
  6. 1. Chien-Ying Lee, Min-Chien Yu, Wu-Tsun Perng, Chun-Che Lin, Ming-Yung Lee, Ya-Lan Chang, Ya-Yun Lai, Yi-Ching Lee, Yu-Hsiang Kuan, James Cheng-Chung Wei, and Hung-Che Shih, (2016/11/12). No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus Casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial. Chinese Journal of Integrative Medicine, Vol. 22 , p.p.1 -8 .[SCI]
  7. Ku MC; Kok VC; Lee MY; Hsu SM; Lee PY; Chang CW; Tyan YS; Juan CW (2016/9/6). Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast medium. Therapeutics and Clinical Risk Management, Vol. 12 , p.p.1357 -1364 .[SCI]
  8. Wan-Ru Chao; Ming-Yung Lee; Alexandra Ruan; Huang Pin Sheng; Jeng-Dong Hsu; Chih-Ping Han; Chiew-Loon Koo (2015/11). Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method. PLOS one, Vol. 10 , No. 11 .[SCI]
  9. Hui-Yu Tsai; Chun-Che Lo; Shann-Horng Yeh; Ming-Yung Lee; Tou-Rong Chene; (2015/11). Ambient and Personal Effective Dose Assessment at the International Arrival Hall of Taichung Airport in Taiwan. Archives of Environmental & Occupational Health, Vol. 70 , No. 5 , p.p.265 -271 .[SCI]
  10. Chien-Ying Lee, Min-Chien Yu, Chun-Che Lin, Ming-Yung Lee, James Cheng-Chung Wei, Hung-Che Shih (2015/8/28). Efficacy and safety of herbal medicine yun-cai tea in the treatment of hyperlipidemia: A double-blind placebo-controlled clinical trial.. Chinese Journal of Integrative Medicine, Vol. 4 , No. 21 , p.p.587 -593 .[SCI]
  11. 韓立明 ; 李名鏞 ; 蔡孟潔 ; 趙婉如 ; 韓志平 ; 王昱婷 (2015/4). Assessing the Influence of Polysomy-17 on HER2 Status in Mucinous Epithelial Ovarian Cancer: A Tissue Microarray Study Using 2010 ToGa Trial Biopsy Specimen Criteria. 婦癌醫學期刊, Vol. 4 , No. 41 , p.p.14 -23 .
  12. Cheng-Hung Hu, Ming-Yung Lee ,Jen Tang (2015/1). OPTIMUM STEP-STRESS ACCELERATED DEGRADATION TEST FOR WIENER DEGRADATION PROCESS UNDER CONSTRAINTS. European Journal of Operational Research, No. 241 , p.p.412 -421 .[SCI]
  13. Wan-Ru Chao, Ming-Yung Lee, Wea-Lung Lin, Chiew-Loon Koo, Gwo-Tarng Sheu, Chih-Ping Han (2014/9). Assessing the HER2 Status in Mucinous Epithelial Ovarian Cancer on the Basis of the 2013 ASCO/CAP Guideline Update. American Journal of Surgical Pathology, Vol. 38 , No. 9 , p.p.1227 -1234 .[SCI]
  14. Wan-Ru Chao; Ming-Yung Lee; Wea-Long Lin; Chi-Kuan Chen; Jau-Chen Lin; Chiew-Loon Koo; Gwo-Tarng Sheu; Chih-Ping Han (2014/4). HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Human Pathology, Vol. 45 , Col. 4 , p.p.810 -81 .[SCI]
  15. Chyong-Mei Chen; James Cheng-Chung Wei; Chao-Min Hsu; Ming-Yung Lee (2014/2/30). Regression analysis of multivariate current status data with dependent censoring: application to ankylosing spondylitis data. Statistics in Medicine, Vol. 30 , No. 5 , p.p.772 -785 .[SCI]
  16. Hui-Yu Tsai; Chun-Che Lo; Shann-Horng Yeh; Ming-Yung Lee; Tou-Rong Chen (2014/1). Ambient and Personal Effective Dose Assessment at the International Arrival Hall of Taichung Airport in Taiwan.. Archives of Environmental & Occupational Health.[SCI]
  17. Pai, Hsiang-Chu; Lee Sheuan; Yen Wen-Jiuan; Lee, Ming-Yung (Accepted). Testing of the Factor Structure of the Sexual Health Knowledge Measure With Young Adolescent Taiwanese Girls. Health Care For Women International.[SSCI]
  18. Jhi-Kai Chang; Chen-Tung Yu; Ming-Yung Lee; KJ Yeo; I-Chang Chang; Hsi-Kai Tsou; James Cheng-Chung Wei (2013/3). Tramadol/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis. Clinical Rheumatology, Vol. 3 , No. 32 , p.p.341 -347 .[SCI]
  19. Chien-Ying Lee; Min-Chien Yu; Chun-Che Lin; Ming-Yung Lee;James Cheng-Chung Wei and Hung-Che Shih (2013/2/28). Efficacy and Safety of Herbal Medicine Yun-Cai Tea in the Treatment of Hyperlipidemia: A Double-Blind Placebo-Controlled Clinical Trial. Chinese Journal of Integrative Medicine.[SCI]
  20. Ying-Hock Teng ; Jung-Jing Teng ; Ming-Yung Lee; Ming-Hong Hsieh ; Yu-Ju Chen (2013/1). Determinants of emergency medical utilization among the elderly population in Taiwan: A national longitudinal cohort study. Archives of Gerontology and Geriatrics, No. 56 , p.p.364 -369 .[SCI]
  21. Chih-Ping Han; Yu-Chen Huang; Ming-Yung Lee; En-Yu Chen; Po-Hui Wang; Shu-Ling Tzeng; Chi-Kuan Chen (2012/12). Anti-cytokeratin CAM5.2 should not be mistaken for cytokeratin 8/18 monoclonal antibody: Comment on “Spindle cell squamous cell carcinoma not expressing stratified but simple epithelial cytokeratin: Efficacy of simple epithelial cytokeratin immunoreactivity”. The Journal of Dermatology, Vol. 12 , No. 39 , p.p.72 -75 .[SCI]
  22. Shan-Ming Chena; Min-Sho Kub; Ming-Yung Lee; Jeng-Dau Tsaib; Ji-Nan Sheu (2012/8). Diagnostic performance of serum interleukin-6 and interleukin-10 levels and clinical predictors in children with rotavirus and norovirus gastroenteritis. Cytokine, Vol. 2 , No. 59 , p.p.299 -304 .[SCI]
  23. Lin SW; Wang YH; Lee MY; Ku MS; Sun HL; Lu KH; Lue KH. (2012/1). Clinical spectrum of acute rhinosinusitis among atopic and nonatopic children in Taiwan.. Int J Pediatr Otorhinolaryngol., Vol. 76 , No. 1 , p.p.70 -75 .[SCI]
  24. Tsai WC, Lee MY, Chen FL, Wang PH, Lin WL, Ruan A, Li YJ, Wang SC, Chiang H, Han CP. (2011/9). The HER2 gene copies per tumor cell either before or after correction for chromosome-17 correlated significantly with HER2 IHC results in epithelial ovarian cancer in a tissue microarray study. Arch Gynecol Obstet., Vol. 284 , No. 3 , p.p.721 -729 .[SCI]
  25. Yang TY, Wei JC, Lee MY, Chen CM, Ueng KC. (2011/9). A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Fufang Danshen (Salvia miltiorrhiza) as Add-on Antihypertensive Therapy in Taiwanese Patients with Uncontrolled Hypertension.. Phytother Res..[SCI]
  26. Lin CK, Lin WL, Chen FL, *Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, *Han CP. (Accepted). Assessing the impact of polysomy-17 on HER2 status as well as the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.. International Journal of Gynecological Pathology, Vol. 3 , No. 4 , p.p.372 -379 .[SCI]
  27. Lin CK, Lin WL, Chen FL, Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, Han CP. (2011/7). Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.. Int J Gynecol Pathol., Vol. 30 , No. 4 , p.p.327 -329 .[SCI]
  28. Yao CC, Lin WL, Lee MY, Han CP (2011/6). Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD).. Breast Cancer Res Treat.[SCI]
  29. Lin WL, Chen FL, Lee MY, Han CP. (2011/6). Source of anti-cytokeratin CAM 5.2 reagent.. Int J Surg Pathol., No. 19 , p.p.409 -410 .[SCI]
  30. Han CP, Lin WL, Wang PH, Yang SF, Lewis JS Jr, Chen CK, Ruan A, Kuo JF, Lee MY, Chiang H. (2011/5). Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.. Histopathology, Vol. 58 , No. 6 , p.p.988 -990 .[SCI]
  31. Lin WL, Chen FL, Kuo JF, Lee MY, Han CP. (2011/4/1). Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2.--a comment on: "Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation,. Experimental and Molecular Pathology, Vol. 90 , No. 2 , p.p.223 -224 .[SCI]
  32. Lin WL, Kuo WH, Chen FL, Lee MY, Ruan A, Tyan YS, Hsu JD, Chiang H, Han CP. (2011/2). Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.. Ann Surg Oncol., Vol. 18 , No. 8 , p.p.2388 -2394 .[SCI]
  33. Ming-Yung Lee (2010/12). Optimal Simple Ramp-Test Based on Wiener Degradation Processes and Inverse Gaussian Distribution. 智慧科技與應用統計學報, Vol. 8 , No. 2 , p.p.21 -34 .
  34. Han CP, Hsu JD, Yao CC, Lee MY, Ruan A, Tyan YS, Yang SF, Chiang H. (2010/11). HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.. Histopathology., Vol. 57 , No. 5 , p.p.763 -764 .[SCI]
  35. Shu-Hsin Lee, Ming-Yung Lee, Tung-Liang Chiang, Maw-Sheng Lee Meng-Chih Lee (2010/9). Child growth from birth to 18 months old born after assisted reproductive technology -results of a national birth cohort study.. International Journal of Nursing Studies., Vol. 9 , No. 47 , p.p. 1159 -1166 .[SCI, SSCI]
  36. Chen HY, Wang CY, Lee MY, Tang PF, Chu YH, Suen MW. (2010/8). A hierarchical categorisation of tasks in mobility disability.. Disabil Rehabil., Vol. 32 , No. 19 , p.p.1586 -1593 .[SSCI]
  37. Han CP, Lee MY, Kok LF, Wu TS, Cheng YW, Wang PH, Yue CH, *Tyan YS (2010/5). A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.. Archives of Gynecology and Obstetrics,, Vol. 5 , No. 281 , p.p.845 -850 .[SCI]
  38. Chih-Ping Han, Jeng-Dong Hsu, Ming-Yung Lee, Lai-Fong Kok, Po-Hui Wang, Yeu-Sheng Tyan, Chung-Chin Yao, (2010/5/1). True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study,. International Journal of Gynecological Pathology, Vol. 29 , No. 3 , p.p.282 -289 .[SCI]
  39. Chiung-Ling Liao, Jeng-Dong Hsu, Ming-Yung Lee, Lai-Fong Kok, Yi-Ju Li, Po-Hui Wang, Chung-Chin Yao and Chih-Ping Han (2010/4). Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?. Virchows Arch., Vol. 4 , No. 456 , Col. , p.p.377 -386 .[SCI]
  40. Kok LF, Lee MY, Tyan YS, Wu TS, Cheng YW, Kung MF, Wang PW, *Han CP. (2010/2). Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stain and cytoplasmic stain in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.. Archives of Gynecology and Obstetrics, Vol. 2 , No. 281 , p.p.293 -300 .[SCI]
  41. Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PW, Koo CL, *Tyan YS (2010/2). Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.. Archives of Gynecology and Obstetrics,, Vol. 2 , No. 281 , p.p.317 -323 .[SCI]
  42. Hsiang-Chu Pai, Ming-Yung Lee, Sheuan Lee (2009/9). Obesity and Perimenopausal Symptoms in Mid-Life Women in Southern Taiwan.. TZU CHI Medical Journal, Vol. 22 , No. 1 , Col. , p.p.289 -296 .
  43. Han, Chih-Ping M.D., Ph.D.; Lee, Ming-Yung Ph.D.; Kok, Lai-Fong M.D.; Ruan, Alexandra; Wu, Tina S. MBA; Cheng, Ya-Wen Ph.D.; Tyan, Yeu-Sheng M.D., Ph.D.; Lin, Ching-Yi M.S., M.D. (2009/9). Adding the p16INK4a Marker to the Traditional 3-marker (ER/Vim/CEA) Panel Engenders No Supplemental Benefit in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study.. International Journal of Gynecological Pathology:, Vol. 28 , No. 5 , Col. , p.p.489 -496 .[SCI]
  44. 3. Chih-Ping Han, Lai-Fong Kok, Ming-Yung Lee, Chung-Chin Yao, Po-Hui Wang, Yeu-Sheng Tyan, Jeng-Dong Hsu, Szu-Wen Tseng. (2009/9/18). p16INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study. Virchows Archiv, Vol. 455 , No. 4 , Col. , p.p.353 -361 .[SCI]
  45. Han CP, Lee MY, Tzeng SL, Yao CC, Wang PH, Cheng YW, Chen SL, Wu TS, Tyan YS, * Kok LF (2008/8/2). Title: Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.. Journal of Experimental & Clinical Cancer Research,, No. 27 .[SCI]

B.會議論文:

  1. 李名鏞,謝淑惠 (2016/5/25)。個人資料隱私權益宣告於電話訪問調查中執行的影響。 智慧科技學會主辦,智慧科技與應用統計學術研討會
  2. 李名鏞 (2014/6/27-2014/7/1)The Estimation of Lifetime Distribution and Model Parameters under
    Two-Phase Wiener Degradation Pr
    武漢大學主辦,2014年海峽兩岸應用統計學術研討會
  3. 李名鏞 (2014/5/16-2014/5/18)Estimation Precision Using Two Different Data Collecting Methods for a Non-Accelerated Degradation Test 逢甲大學, 國立中興大學主辦,2014第九屆海峽兩岸機率與統計學術研討會
  4. Ming-Yung Lee ; Cheng-Hung Hu (2013/7). Using Latent Variable to Estimate Parameters of Inverse Gaussian Distribution Based on Time-Censored Wiener Degradation Data. Proceedings of the Institute of Industrial Engineers Asian Conference 2013 (p.p.29-35). :Springer Singapore.
  5. Hu, Cheng-Hung ; Lee, Ming-Yung (2012/12). Optimum step-stress accelerated degradation testing plan based on D-optimality. 大葉大學,工業工程學會年會暨學術研討會. .

D.研究報告(研究計畫):

  1. 李名鏞 (2014/8/1 - 2015/7/31)具隨機改變點之兩相Wiener衰變模式下,產品壽命分配與參數之估計及其模型選擇 (科技部計畫,103-2221-E-126 -016 - )
  2. 韓志平,李名鏞 (2012/8/1 - 2013/7/31)探索上皮性卵巢癌的潛在治療標靶 (科技部計畫,101-2314-B-040-006- )
  3. 李名鏞 (2010/8/1 - 2011/7/31)Wiener加速衰變模式為基礎,在時間設限下的最佳加速衰變實驗計畫 (科技部計畫,NSC 99-2118-M-126 -002 )
  4. 李名鏞 (2009/11/1 - 2010/7/31)加速衰變實驗之壽命分配估計與最佳實驗配置 (科技部計畫,NSC 98-2118-M-126 -002 )
  5. 李名鏞 (2015/8/1 - 2016/7/31)畢業生流向調查追蹤計畫:校友就業表現與在校生職能測驗關聯性分析 (靜宜大學,PU104-SPR1-003)
  6. 李名鏞 (2013/10/15 - 2014/7/31)具有損壞監測下之最佳加速衰變試驗 (靜宜大學,PU102-11100- A11)
  7. 李名鏞 (2013/8/1 - 2014/7/31)102學年度靜宜大學「統計資訊學系學生校外實習的學習成效」之研究 (靜宜大學,PU102-IOS-004)
  8. 李名鏞,吳俊憲 (2012/8/1 - 2013/7/31)靜宜大學教學評量之研究():回顧與檢討 (靜宜大學,PU101-SPR2-001)



 

微軟LOGO
微軟專業學程
資料科學暨大數據分析與應用學系
地 址:(43301) 臺中市沙鹿區臺灣大道7段200號 資料科學暨大數據分析與應用學系
電 話:886-4 26328001 Ext. 15051,15052
傳 真:(04) 2631-4846
信 箱:pu20250@pu.edu.tw

為提供更為穩定的瀏覽品質與使用體驗,建議使用:最新版Google Chrome、Mozilla Firefox或Microsoft Edge等瀏覽器
最佳解析度1024*768 以上
本網站著作權屬於靜宜大學資料科學暨大數據分析與應用學系,請詳見使用規則。隱私權聲明